Oncology financial navigation offered as part of routine care

Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation

Not applicable Interventional University of Alabama at Birmingham · NCT07281287

This project will try offering financial navigation as part of routine cancer care at UAB to see if it reduces patients' financial hardship and improves quality of life and distress.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment40 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity of Alabama at Birmingham Academic / other
Locations1 site (Birmingham, Alabama)
Trial IDNCT07281287 on ClinicalTrials.gov

What this trial studies

Using a pragmatic hybrid effectiveness–implementation design guided by the RE-AIM Extension for Equitable Sustainability framework, investigators will track how financial navigation is implemented in routine oncology care at UAB and measure related outcomes. They will analyze existing patient-reported outcome data collected since 2020, electronic medical records, and qualitative interviews with patients and staff. The study links implementation strategies to implementation outcomes and to patient-level outcomes including financial hardship, quality of life, and psychological distress, with planned analyses of inequities by race, residence, and insurance status. Findings are intended to identify practical strategies to improve equitable delivery of financial navigation within the health system.

Who should consider this trial

Good fit: Ideal participants are patients with cancer receiving care at UAB Medical Oncology who complete routine patient-reported outcome measures and who may receive financial navigation services.

Not a fit: Patients treated outside UAB or those whose financial problems cannot be resolved by navigation (for example, ineligible for assistance or facing structural insurance barriers) may not experience benefit.

Why it matters

Potential benefit: If successful, embedding financial navigation into routine oncology care could lower patients' out-of-pocket costs, reduce financial distress, and improve quality of life.

How similar studies have performed: Prior pilot studies and smaller trials suggest financial navigation can lower out-of-pocket costs and distress, but large pragmatic implementation studies of routine delivery are still limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Aim 1:

Inclusion criteria: As oncology financial navigation will be implemented as standard of care, implementation outcomes will be evaluated for:

1. All patients with cancer seen at the University of Alabama at Birmingham (UAB) Medical Oncology clinic
2. UAB oncology financial navigators

Exclusion criteria: None.

Aim 2:

Inclusion criteria: This will be a secondary data analysis of patient-reported data routinely collected since 2020, which will include:

1. Patients with cancer seen at the UAB Medical Oncology clinic
2. Patients with non-missing patient-reported outcome data

Exclusion criteria: None.

Aim 3:

Inclusion criteria:

1. Patients who have received oncology financial navigation
2. Providers (oncology financial navigators, social workers, nurse managers, oncologists) involved with the oncology financial navigation program
3. Health system team members (billing specialists, cancer service line leadership) involved with the oncology financial navigation program

Exclusion criteria: None.

Where this trial is running

Birmingham, Alabama

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions OncologyFinancial ToxicityCounselingFinancial NavigationOut of pocket costoncology Financial hardship
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.